ADC Therapeutics
Company Overview
Overall Headcount Trend
Overall Headcount Trend
Company growth over the last 12 months
Salaries
Community Salary Data
Help build salary transparency at ADC Therapeutics. Share your compensation anonymously.
Reviews
Jobs
About ADC Therapeutics
ADC Therapeutics is a commercial-stage global pioneer in the field of antibody drug conjugates (ADCs). Our goal is to be a leading ADC company that transforms the lives of those impacted by cancer. We are a pioneer in the ADC field with specialized capabilities unique to ADCs from clinical to manufacturing and commercialization with a proven track record that includes an approved and marketed product. Our CD19-directed ADC ZYNLONTA® (loncastuximab tesirine-lpyl) received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy. In addition to ZYNLONTA, ADC Therapeutics is leveraging its expertise to advance IND-enabling activities for a next-generation PSMA-targeting ADC.Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in New Jersey. Our highly skilled global team is committed to confronting cancer with the full potential of our science and transforming the treatment paradigm for patients with cancer.For more information, please visit https://www.adctherapeutics.com/.
Company Information
- Company Type
- In-House Team
- Company Size
- Founded
- 2011
- Headquarters
- Lausanne
Why Work at ADC Therapeutics?
Discover what makes ADC Therapeutics a great place to build your marketing career. View salary data, benefits, and employee insights on the other tabs.
